A detailed history of First Business Financial Services, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, First Business Financial Services, Inc. holds 7,365 shares of ABBV stock, worth $1.5 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
7,365
Previous 8,558 13.94%
Holding current value
$1.5 Million
Previous $1.56 Million 18.93%
% of portfolio
0.13%
Previous 0.17%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$154.79 - $180.76 $184,664 - $215,646
-1,193 Reduced 13.94%
7,365 $1.26 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $191,624 - $218,337
1,199 Added 16.29%
8,558 $1.56 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $874,860 - $985,299
-6,358 Reduced 46.35%
7,359 $1.14 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $11,889 - $13,763
89 Added 0.65%
13,717 $2.04 Million
Q2 2023

Aug 07, 2023

SELL
$132.51 - $164.9 $18,551 - $23,086
-140 Reduced 1.02%
13,628 $1.84 Million
Q1 2023

May 08, 2023

SELL
$144.61 - $166.54 $5,061 - $5,828
-35 Reduced 0.25%
13,768 $2.19 Million
Q4 2022

Feb 02, 2023

BUY
$138.31 - $165.87 $237,201 - $284,467
1,715 Added 14.19%
13,803 $2.23 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $11,676 - $13,391
87 Added 0.72%
12,088 $1.62 Million
Q2 2022

Aug 02, 2022

BUY
$137.62 - $174.96 $62,204 - $79,081
452 Added 3.91%
12,001 $1.84 Million
Q1 2022

May 09, 2022

SELL
$131.98 - $163.75 $22,568 - $28,001
-171 Reduced 1.46%
11,549 $1.87 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $263,203 - $333,028
2,450 Added 26.43%
11,720 $1.59 Million
Q3 2021

Oct 26, 2021

BUY
$106.4 - $120.78 $729,691 - $828,309
6,858 Added 284.33%
9,270 $1 Million
Q1 2021

Apr 20, 2021

BUY
$102.3 - $112.62 $21,073 - $23,199
206 Added 9.34%
2,412 $261,000
Q4 2020

Jan 28, 2021

SELL
$80.49 - $108.67 $17,627 - $23,798
-219 Reduced 9.03%
2,206 $236,000
Q2 2020

Aug 12, 2020

BUY
$73.37 - $98.18 $177,922 - $238,086
2,425 New
2,425 $238,000
Q1 2020

May 01, 2020

SELL
$64.5 - $97.79 $166,732 - $252,787
-2,585 Closed
0 $0
Q4 2019

Feb 10, 2020

SELL
$72.13 - $90.25 $339,155 - $424,355
-4,702 Reduced 64.53%
2,585 $229,000
Q3 2019

Nov 05, 2019

SELL
$62.98 - $75.72 $12,596 - $15,144
-200 Reduced 2.67%
7,287 $552,000
Q2 2019

Jul 24, 2019

SELL
$65.7 - $83.98 $28,973 - $37,035
-441 Reduced 5.56%
7,487 $544,000
Q1 2019

May 03, 2019

SELL
$77.14 - $90.79 $25,764 - $30,323
-334 Reduced 4.04%
7,928 $639,000
Q4 2018

Feb 06, 2019

BUY
$77.85 - $96.01 $37,212 - $45,892
478 Added 6.14%
8,262 $762,000
Q2 2018

Aug 06, 2018

SELL
$89.78 - $106.23 $24,330 - $28,788
-271 Reduced 3.36%
7,784 $721,000
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $190,184 - $254,675
-2,067 Reduced 20.42%
8,055 $762,000
Q4 2017

Feb 07, 2018

BUY
$89.56 - $98.21 $115,442 - $126,592
1,289 Added 14.59%
10,122 $979,000
Q3 2017

Oct 26, 2017

BUY
$69.85 - $89.22 $64,261 - $82,082
920 Added 11.63%
8,833 $785,000
Q2 2017

Aug 09, 2017

BUY
N/A
7,913
7,913 $574,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track First Business Financial Services, Inc. Portfolio

Follow First Business Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Business Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Business Financial Services, Inc. with notifications on news.